Benign Design: Environmental Studies Leading to Sustainable Pharmaceuticals
Project Details by Fiscal Year
2020 Fiscal Year Funding Amount
$415,000
Fund Source
Environment & Natural Resources Trust Fund
Recipient
U of MN
Recipient Type
Public College/University
Status
In Progress
Start Date
July 2019
End Date
June 2022
Counties Affected
Statewide
Project Overview
We will identify wastewater treatment and natural processes that prevent the formation of highly toxic byproducts from fluoro-pharmaceuticals. This will lead to improved treatment and rules for better pharmaceutical design.
Project Details
Competitive Grant Making Body
Project Details: 2020 Fiscal Year
Legal Citation / Subdivision
M.L. 2019, First Special Session, Chp. 4, Art. 2, Sec. 2, Subd. 04b
Appropriation Language
$415,000 the first year is from the trust fund to the Board of Regents of the University of Minnesota to determine how to best remove harmful fluorinated pharmaceuticals during wastewater treatment and to develop alternate versions of these compounds that are medically useful but environmentally harmless. This appropriation is subject to Minnesota Statutes, section 116P.10.
2020 Fiscal Year Funding Amount
$415,000
Other Funds Leveraged
$0
Proposed Measurable Outcome(s)
Click on 'Work Plan' under 'Project Details'.
Measurable Outcome(s)
Click on 'Work Plan' under 'Project Details'.
Project Manager
First Name
William
Last Name
Arnold
Organization Name
U of MN
Street Address
500 Pillsbury Dr SE
City
Minneapolis
State
MN
Zip Code
55455
Phone
(612) 625-8582
Email
arnol032@umn.edu
Administered By
Administered by